CD4 and cancer: The thyrointegrin expression permits certain endogenous T4 metabolites, such as tetrac, to disrupt cancer cell metabolism, without significantly affecting normal, nonmalignant cells in which the thyrointegrin is not active, non-accessible, or is present only in minute quantities.